mounjaro tirzepatide fda label prescribing information pdf Device Database Mounjaro® (Tirzepatide) Injection Overview and

Expected Results and Timeframes So, how long must you wait to feel and see the effects of tirzepatide

A large proportion of participants achieved key weight-loss milestones (5% to 25%), and treatment was also associated with improvements in both general (SF-36v2) and obesity-specific (IWQOL-Lite-CT) quality of life

14.2 Monotherapy Use Of Mounjaro In Adult Patients With Type 2 Diabetes Mellitus SURPASS-1 (NCT03954834) was a 40-week double-blind trial that randomized 478 adult patients with type 2 diabetes mellitus with inadequate glycemic control with diet and exercise to MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg, or placebo once weekly

5 WARNINGS AND PRECAUTIONS Directions And Dosage 2 DOSAGE AND ADMINISTRATION 3 DOSAGE FORMS AND STRENGTHS Injection: Clear, colorless to slightly yellow solution in pre-filled single-dose pens, single-dose vials, multi-dose vials, or single-patient-use KwikPens, each available in the following strengths

This plan includes a balanced diet and regular physical activity, tailored to meet each patients unique needs